Alpha Teknova Sees Q3 2026 Revenue Of $12.5M-$12.7M, Up 19% - 21% YoY
Alpha Teknova, Inc. ("Teknova") (NASDAQ:TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today